Scribble acts as an oncogene in Eμ-myc-driven lymphoma

被引:0
|
作者
E D Hawkins
J Oliaro
K M Ramsbottom
A Newbold
P O Humbert
R W Johnstone
S M Russell
机构
[1] Cancer Immunology Program,Sir Peter MacCallum Department of Oncology
[2] Peter MacCallum Cancer Centre,Department of Pathology
[3] The University of Melbourne,Department of Biochemistry and Molecular Biology
[4] Melbourne,undefined
[5] Victoria,undefined
[6] Australia,undefined
[7] Cancer Therapeutics Programs,undefined
[8] Peter MacCallum Cancer Centre,undefined
[9] Cell Cycle and Cancer Genetics Laboratory,undefined
[10] Peter MacCallum Cancer Centre,undefined
[11] The University of Melbourne,undefined
[12] Melbourne,undefined
[13] Victoria,undefined
[14] Australia,undefined
[15] The University of Melbourne,undefined
[16] Melbourne,undefined
[17] Victoria,undefined
[18] Cell cycle and Cancer Genetics Laboratory,undefined
[19] Peter MacCallum Cancer Centre,undefined
[20] Centre for Micro-Photonics,undefined
[21] Swinburne University of Technology,undefined
[22] 9Current address: Imperial College London,undefined
[23] Sir Alexander Fleming Building,undefined
[24] SW72AZ,undefined
[25] London,undefined
[26] UK.,undefined
来源
Oncogene | 2016年 / 35卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Scribble complex proteins maintain apicobasal polarity, regulate cell fate determination and function as tumour suppressors in epithelial tissue. Despite evidence that the function of Scribble is maintained in the lymphocyte lineage, we still understand little about its role as a tumour suppressor in haematological malignancies. Using the Eμ-myc model of Burkitt’s lymphoma we investigated the role of Scribble in lymphomagenesis. We found that contrary to its well-documented tumour suppressor role in epithelial tissue, loss of Scribble expression delayed the expansion of peripheral B cells and delayed the onset of Eμ-myc-driven lymphoma. This was despite upregulated ERK phosphorylation levels in Scribble-deficient tumours, which are associated with loss of Scribble expression and the development of more aggressive Burkitt’s lymphoma. Interestingly, the developmental stage of lymphoma was unaffected by Scribble expression challenging any role for Scribble in fate determination in the haematopoetic lineage. These data provide evidence for oncogenic properties of Scribble in Myc-driven B-cell lymphomagenesis, reinforcing recent findings that overexpression of a mutant form of Scribble can act as an oncogene in epithelial cells. Our results support the growing appreciation that the tumour regulatory functions of Scribble, and other polarity protein family members, are context dependent.
引用
收藏
页码:1193 / 1197
页数:4
相关论文
共 50 条
  • [41] WDR5 IS A MYC COFACTOR REQUIRED FOR MYC-DRIVEN TUMORIGENESIS
    不详
    CANCER DISCOVERY, 2015, 5 (05) : 461 - 461
  • [42] Synthetic-lethal strategies for MYC-driven cancers
    Goga, Andrei
    MOLECULAR CANCER THERAPEUTICS, 2017, 16 (10)
  • [43] Interrogating the function of histone methyltransferases in MYC-driven medulloblastoma
    Mercier, Audrey L.
    Stripay, Jennifer L.
    Bilokapic, Silvij A.
    Williams, Justin
    Nance, Stephanie
    Liu, Jingjing
    Philips, Steven
    Kandikonda, Suresh
    Morfouace, Marie
    Bramoulle, Aude
    Advedissian, Tamara
    Yu, Jiyang
    Peng, Junmin
    Ansari, Aseem
    Halic, Mario
    Durbin, Adam
    Vakoc, Christopher
    Roussel, Martine F.
    CANCER RESEARCH, 2022, 82 (12)
  • [44] MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint
    Smith, Benjamin A. H.
    Deutzmann, Anja
    Correa, Kristina M.
    Delaveris, Corleone S.
    Dhanasekaran, Renumathy
    Dove, Christopher G.
    Sullivan, Delaney K.
    Wisnovsky, Simon
    Stark, Jessica C.
    V. Pluvinage, John
    Swaminathan, Srividya
    Riley, Nicholas M.
    Rajan, Anand
    Majeti, Ravindra
    Felsher, Dean W.
    Bertozzi, Carolyn R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (11)
  • [45] The role of PRMT5 in MYC-driven medulloblastoma
    Chaturvedi, Nagendra K.
    Kesherwani, Varun
    Kling, Matthew J.
    Ray, Sutapa
    McGuire, Timothy R.
    Joshi, Shantaram S.
    Sharp, J. Graham
    Coulter, Don W.
    CANCER RESEARCH, 2019, 79 (13)
  • [46] FoxO3 suppresses Myc-driven lymphomagenesis
    C J Vandenberg
    N Motoyama
    S Cory
    Cell Death & Disease, 2016, 7 : e2046 - e2046
  • [47] The spliceosome, a potential Achilles heel of MYC-driven tumors
    Olga Anczuków
    Adrian R. Krainer
    Genome Medicine, 7
  • [48] INTERROGATING THE ROLE OF EPIGENETIC REGULATORS IN MYC-DRIVEN MEDULLOBLASTOMA
    Stripay, Jennifer
    Morfouace, Marie
    Vakoc, Christopher
    Roussel, Martine
    NEURO-ONCOLOGY, 2019, 21 : 108 - 108
  • [49] MYC-Driven SCLC Has Unique Metabolic Vulnerabilities
    Wait, S. J.
    Chalishazar, M. D.
    Huang, F.
    Bomalaski, J. S.
    DeBerardinis, R. J.
    Oliver, T. G.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : S14 - S14
  • [50] Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
    D'Avola, Annalisa
    Kluckova, Katarina
    Finch, Andrew J.
    Riches, John C.
    ONCOTARGETS AND THERAPY, 2023, 16 : 371 - 383